Crystal Adam's Form 4 filing
C4 Therapeutics, Inc. (CCCC) · filed Jul 6, 2021
- Accession no.
- 0001209191-21-045691
- Filed
- Jul 6, 2021
- Trade date
- Jul 1, 2021
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $569.7K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Crystal AdamCIK 0001825445 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 | Common Stock | MOption exerciseAcquired | +15,000 | $6.50 | +$97,500 | 15,000 | Direct | |
| Jul 1, 2021 | Common Stock | SSaleDisposed | −13,300 | $37.93 | −$504,469 | 1,700 | Direct | |
| Jul 1, 2021 | Common Stock | SSaleDisposed | −1,700 | $38.38 | −$65,246 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 142,292 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.